ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.

Giacomo Frati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.